Académique Documents
Professionnel Documents
Culture Documents
Heru Sundaru
Percentage
100
10
0.1
0.01
1920
1940
1960
year
1980
2000
2020
Age
Sample of
study
year
Prevalence
(%)
England
4 - 12
5806
6056
1973
1986
2.0
4.1
Scotlandia
8 - 13
3403
4034
1989
1994
10.2
19.6
Japan
Children
Taiwan
55388
45675
1982
1992
3.3
4.6
7 - 15
23678
92471
1974
1991
1.3
5.8
22268
2457
1967
1992
3 - 5.5
19.5
Singapore
4 - 17
6 - 14
East Jerman
(n=2623)
OR
CI 95%
Asthma ever
9.3 +
7.2
1.3
1.1;1.6
current Asthma
5.9
3.9
1.5
1.2;1.9
Bronchitis
15.9
33.7
0.4
0.3;0.4
Atopic Rhinitis
8.6
2.7
3.4
2.6;4.4
17.0
26.8
0.6
0.5;0.6
8.7
9.6
0.9
0.8;1.1
- Night cough
3.4
6.1
0.5
0.4;0.7
- exercise cough
11.7 +
14.2
0.8
0.7;0.9
- SO2
14g/m3
150 g/m3
- PM10
47g/m3
80 g/m3
Symptoms
- Wheezing
- Short of breath
Poluted
Current
prevalence
Cumulative
prevalence
8.9%
6.9%
3.4%
10.9%
7.6%
3.8%
Nose symptoms
Rash 12 months
11
4.4
97
38.8
47
18.8
27
3.54
274
35.96
43
5.64
22
5.77
86
22.57
1.84
47
2.09
733
32.59
54
2.4
19
7.36
88
34.11
0.39
24
17.47
358
61.94
101
17.47
72
9.01
420
52.56
97
12.14
222
4.21
2056
38.96
350
6.63
Nose symptoms
Rash 12 months
147
5.16
550
19.3
90
3.16
111
4.31
828
32.14
164
6.37
107
7.73
370
26.71
97
7.00
193
5.47
619
17.56
191
5.42
558
5.40
2367
22.40
542
5.24
Ciater, Subang
Pegaden, Subang
Pagaden, Subang
Cijambe, Subang
Central Jakarta
Subang (rural)
Variable
N = 3840
N = 3019
WHEZEV
389
10.1
399
13.2
WHEZ12
288
7.5
290
9.6
ASTHMAEV
298
7.8
353
11.7
PNOSEEV
1023
26.6
1619
53.6
PNOSE12
843
22.0
1046
34.6
RASHEV
220
5.7
406
13.4
RASH12
178
4.6
303
10.0
ECZEMAEV
182
4.7
475
15.7
Heru et al. 2005
(min-max)
Subang
Kalijati
Lapangan Bintang
27.98
(23.39-33.22)
26.43
(21.10-33.62)
26.10
(22.49-31.09)
59.91
(27.12-78.24)
69.17
(26.96-95.42)
67.59
(24.24-91.54)
PM10 (g/m3 )
89.37
(46.71-276.13)
85.76
(44.79-165.81)
72.73
(39.75-148.56)
SO2 (g/m3)
30.75
(16.54-50.46)
114.08
(110.10-118.59)
111.76
(108.23-121.30)
CO (mg/m3 )
1.56
(0.50-3.67)
0.62
(0.14-2.88)
0.33
(0.11-0.72)
O3 (g/m3 )
86.81
(39.44-301.15)
33.17
(9.90-75.93)
54.17
(25.77-99.75)
NO2 (g/m3 )
60.31
(13.57-128.56)
16.98
(7.08-38.49)
13.87
(2.38-44.54)
Year
1989 (baseline)
1990 (preintervention)
1991 (postintervention)
S
KT
16,1 (14,2-18,0)
19,8 (18,0-21,6)
13,9 (12,1-15,7)
16,8 (15,1-18,5)
11,7 (10,0-13,4)
11,1 (9,7-12,5)
Phlegn
S
KT
16,8 (14,9-18,7)
19,2 (17,4-21,0)
13,2 (11,4-15,0)
14,2 (12,6-15,8)
9,4 (7,9-10,9)
8,1 (6,9-9,3)
Wheezing or
asthmatic diagnosis
S
KT
11,3 (9,7-12,9)
12,7 (11,2-14,2)
10,5 (8,9-12,1)
11,2 (9,8-12,6)
9,2 (7,7-10,7)
9,3 (8,0-10,6)
Wheezing
S
KT
7,8 (6,4-9,2)
10,5 (9,1-11,9)
9,5 (8,0-11,0)
9,9 (8,6-11,2)
6,9 (5,6-8,2)
7,2 (6,0-8,4)
Asthma
S
KT
7,4 (6,0-8,8)
7,1 (6,0-8,2)
6,9 (5,6-8,2)
6,9 (5,8-8,0)
5,8 (4,6-7,0)
6,3 (5,2-7,4)
S
KT
35,6 (33,1-38,1)
38,1 (35,9-40,3)
31,0 (28,6-33,4)
31,4 (29,3-33,5)
32,6 (30,2-35,0)
32,4 (30,2-34,5)
S : Southern
KT : Kwai Tsing
Peters J, Hedley AJ, Wong CM, Lam TH, Ong SG, International Journal of Epidemiology 1996;25:821-828
East Jerman
(n=2623)
OR
CI 95%
Asthma ever
9.3 +
7.2
1.3
1.1;1.6
current Asthma
5.9
3.9
1.5
1.2;1.9
Bronchitis
15.9
33.7
0.4
0.3;0.4
Atopic Rhinitis
8.6
2.7
3.4
2.6;4.4
17.0
26.8
0.6
0.5;0.6
8.7
9.6
0.9
0.8;1.1
- Night cough
3.4
6.1
0.5
0.4;0.7
- exercise cough
11.7 +
14.2
0.8
0.7;0.9
- SO2
14g/m3
150 g/m3
- PM10
47g/m3
80 g/m3
Symptoms
- Wheezing
- Short of breath
Poluted
Asthma
Rhinitis
Urticaria
1.
2.
3.
21 (7,0%)
17 (5,7%)
10 (3,7%)
21 (7,0%)
26 (8,7%)
14 (5,2%)
39 (13,0%)
31 (10,3%)
17 (6,3%)
Atopy
104 (34,7 %)
99 (33,0 %)
91 (33,5 %)
Non atopy
196 (65,3 %)
201 (67,0 %)
181 (66,5 %)
Total
93 (89,4 %)
104
89 (89,9 %)
99
3. Administrative staffers
89 (97,8 %)
91
271 (92,2 %)
294
Place of work
Total
Latex (+)
(2,2 %)
23 (7,8 %)
Control
(N=274)
%
Asthma
(N=207)
%
216
(78.83)
58
(21.17)
47
(22.71)
160
(77.29)
225
(82.12)
49
(17.88)
63
(30.43)
144
(69.57)
239
(87.23)
35
(12.77)
114
(55.07)
93
(44.93)
Crude OR
(95% IC)
1
12.68
(7.50;21.44)
0.0000
1
10.50
(6.35;17.34)
0.0000
1
5.57
(3.44;9.01)
0.0000
Control
(N=274)
%
Asthma
(N=207)
%
259
(94.53)
15
(5.47)
199
(96.14)
8
(3.86)
266
(97.08)
8
(2.92)
193
(93.24)
14
(6.76)
267
(97.45)
7
(2.55)
194
(93.72)
13
(6.28)
209
(76.28)
65
(23.72)
43
(20.77)
164
(79.23)
Crude OR
(95% IC)
1
0.69
(0.29;1.67)
0.4132
Cat
+
C.albicans
+
Atopy
+
1
2.41
(0.99;6.56)
0.0460
1
2.56
(1.00;6.56)
0.0429
1
12.26
(7.27;20.69)
0.0000
Control
(N=274)
%
Asthma
(N=207)
%
176
(71.26)
71
(28.74)
61
(50.83)
59
(49.17)
193
(78.14)
54
(21.86)
73
(60.83)
47
(39.17)
206
(83.40)
41
(16.60)
96
(80.00)
24
(20.00)
Crude OR
(95% IC)
1
2.40
(1.51;3.80)
0.0001
1
2.30
(1.42;3.73)
0.0005
1
1.26
(0.72;2.20)
0.4240
Control
(N=274)
%
Asthma
(N=207)
%
204
(97.17)
7
(2.83)
113
(94.17)
7
(5.83)
236
(95.55)
11
(4.45)
113
(93.24)
7
(5.83)
246
(99.60)
1
(0.40)
113
(94.17)
7
(5.83)
158
(63.97)
89
(36.03)
53
(44.17)
67
(55.83)
Crude OR
(95% IC)
1
2.12
(0.72;6.23)
0.1599
Cat
+
C.albicans
+
Atopy
+
1
1.33
(0.50;3.53)
0.5664
1
15.24
(1.79;129.89)
0.0008
1
2.24
(1.43;3.53)
0.0003
Atopy
asthma
DX
5681
Adult
48.27%
9.7%
DX asma
4451
(JB)
9-11 th
36.7%
5.9%
Current asma
2335
(JT)
9-11 th
18.2%
3.9%
Current asma
979
10
14.3%
8.3%
Wheezing 12
mth
1339
(Sidney)
8-11 th
42%
24%
Current asma
926
(Belmon)
8-11 th
39%
38%
Current asma
Atopy
Asthma
Yemaneran 1997
Rural
861
5-20 yr
12%
1%
Africa
urban
2194
5-20 yr
4%
4%
Leung 1997
(Hongkong)
Malaysia
409
12-18 yr
64%
4,9%
1062
12-18 yr
58%
3.7%
China
737
12-18 yr
49%
1.1%
Urban
350
>15 yr
35%
4.4%
Rural
286
>15 yr
22%
3,5%
Hongkong
Nyan 2001 (Gambia)
location
Sensitization
TDR
Asthma
prevalence (%)
Charpin, dkk
Marseille
Briancon
28,0
10,0
4
2
Faniran, dkk
Australia
Nigeria
28,2
20,7
21,9
10,2
Wieringa, dkk
Urban Antwerp
Suburb Antwero
26,0
17,0
7
4
Von Mutius
Jerman Barat
Jerman Timur
10,3
4,20
5,9
3,9
Leung, dkk
Hongkong
Kota kinibalu
San Bu
55,4
60,2
42,7
3,7
4,9
1,1
This studi
Jakarta
77,3
7,5
Subang
49,2
9,5
Subang (Rural)
Control
(n=164)
Case
(n=135)
P-value
Control
(n=138)
Case
(n=135)
P-value
Der p1
(g/g dust)
0.28
(0.23;0.35)
0.29
(0.23;0.35)
0.9501
0.28
(0.22;0.36)
0.44
(0.32;0.61)
0.0382
Der f1
(g/g dust)
1.28
(1.07;1.53)
1.49
(1.24;1.80)
0.2371
0.33
(0.26;0.43)
0.49
(0.32;0.74)
0.1139
Group I
(g/g dust)
1.85
(1.58;2.16)
2.08
(1.78;2.42)
0.3021
0.83
(0.66;1.04)
1.24
(0.89;1.72)
0.0514
* Geometric
SUMMARY
Compare to developed countries the
prevalence of asthma and allergic disease is
still low, although there are tendencies to
increase
Other factor should have a role beside atopy
in determining the prevalence of asthma and
allergy in Indonesia